Technology News and Research

RSS

FCC makes recommendations for using high-speed broadband networks to increase use of telemedicine

Emerging Healthcare Solutions, Inc. was pleased on learning that The Federal Communication Commission’s national strategy for broadband issued today emphasizes health care, including electronic health record adoption and use, health data exchanges, telemedicine and mobile health services.

18 Mar 2010

McGill researchers pioneer major breakthrough in DNA nanotechnology

A team of McGill Chemistry Department researchers led by Dr. Hanadi Sleiman has achieved a major breakthrough in the development of nanotubes - tiny "magic bullets" that could one day deliver drugs to specific diseased cells.

18 Mar 2010

Virtuoso Digital Pathology Software: BioImagene adds Companion Algorithms for colon cancer

BioImagene, Inc., the leading provider of end-to-end digital pathology solutions, today announced the availability of Companion Algorithms™ for colon cancer in their Virtuoso™ Digital Pathology Software. BioImagene’s Companion Algorithms are unique in the digital pathology industry as they are specific to a biomarker and a tissue type. Therefore, pathologists are not faced with the challenges of customizing generic algorithms in order to make them work.

18 Mar 2010

U.N. Secretary-General launches report aimed at meeting MDGs by 2015

U.N. Secretary-General Ban Ki-moon "warned on Tuesday that failure to meet" Millennium Development Goal (MDG) targets by the 2015 deadline could result in "increased instability, violence, epidemic diseases and overpopulation," Agence France-Presse/Mail & Guardian reports (3/17).

18 Mar 2010

Bone Biologics receives Notice of Allowance of patent claims that protects formation of cartilage by UCB-1

Bone Biologics, Inc. announced today that it has received a US Patent Office Notice of Allowance of patent claims which strongly protects the formation of cartilage by the unique NELL 1 protein (UCB-1). Additional claims cover the surgical application of the NELL 1 (UCB-1) protein by several delivery agents.

18 Mar 2010

NIST and HHS to develop software tools to support health IT testing infrastructure

Fully incorporating modern information technology into the healthcare system promises many benefits, including better quality care, less paperwork and fewer medical errors while reducing unnecessary costs. In any such critical application, however, it's important to ensure that the new technology behaves as expected.

18 Mar 2010

FDA approves Envoy Medical's prosthetic hearing restoration device

On March 17, 2010 the FDA gave approval to Envoy Medical Corporation to market a "First of its Kind" prosthetic hearing restoration device. The approval follows a December 18, 2009 unanimous 15 to 0 vote by an independent advisory panel in favor of approving the Esteem® for moderate to severe sensorineural hearing loss. The FDA chose an expedited review process, noting that they believe the Esteem® "represents a breakthrough technology."

18 Mar 2010

RainDance Technologies partners with Ambry Genetics to provide sequence enrichment solution for clinical and research studies

Ambry Genetics and RainDance Technologies today jointly announced at the Annual CHI Next Generation Sequencing Conference in San Diego, CA their partnership utilizing the RDT 1000 for sequence enrichment and resequencing validation.

18 Mar 2010

Enzo Biochem announces supply and distribution agreement between Enzo Life Sciences and Cancer Genetics

Enzo Biochem, Inc., a vertically integrated biotechnology company engaged in the research, development, manufacture, licensing and marketing of innovative health care products, platforms and services based on molecular and cellular technologies, announced today a supply and distribution agreement between Enzo Life Sciences and privately-owned Cancer Genetics Inc., a leading producer of nucleic acid products used in genomic research.

18 Mar 2010

Biomoda enters into agreements with syndicate of institutional investors for up to $2.0M

Cancer diagnostics company Biomoda, Inc. (www.biomoda.com) today announced that it has entered into agreements with a syndicate of institutional investors for up to $2.0 million. LifeTech Capital, a division of Aurora Capital LLC, acted as the exclusive placement agent for the financing.

17 Mar 2010

Industry game changers to watch in healthcare IT

Whatever the outcome of healthcare reform, this much is clear: Information technology will play a critical role in the improvement and delivery of patient outcomes. So, will government contractors — they already are. So, who’s in the lead?

17 Mar 2010

Zogenix announces the initiation of pivotal Phase 3 clinical trial with ZX002

Zogenix, Inc., a privately held pharmaceutical company, announced that it has initiated a pivotal Phase 3 clinical trial with ZX002, a novel, oral, controlled-release formulation of hydrocodone without acetaminophen. ZX002 is being developed for the treatment of moderate to severe pain in individuals who require around-the-clock opioid therapy for the control of pain.

17 Mar 2010

Use of simulation technology in Florida's nursing education programs expanding

A recent report from the Florida Center for Nursing found that pre-licensure nursing education programs turned away more than 13,000 qualified applicants during 2008-2009, and, for the third year in a row, limited access to clinical training sites was reported as a major barrier for nursing education programs in Florida.

17 Mar 2010

ImmunoCellular Therapeutics receives Notice of Allowance covering antibodies targeting pancreatic cancer

ImmunoCellular Therapeutics, Ltd., a biotechnology company that is developing immune based therapies for the treatment of various forms of cancer, announced today it received a Notice of Allowance from the United States Patent and Trademark Office covering technology relating to monoclonal antibodies that bind to certain epitopes present on pancreatic cancers. This patent will broaden the Company’s proprietary intellectual property for ICT-109 and ICT-37, two of the Company’s monoclonal antibody product candidates.

17 Mar 2010

CDISC approves Nextrials as one of 15 registered solutions providers

Nextrials, Inc., a leader in clinical research software and services, has been approved by the Clinical Data Interchange Standards Consortium as one of 15 registered solutions providers, and is the only company offering an electronic data capture (EDC) product supporting the CDISC Healthcare Link Initiative.

17 Mar 2010

ALS TDI, Aestus Therapeutics to test potential small-molecule compounds to stop progression of ALS

The ALS Therapy Development Institute and Aestus Therapeutics, Inc., announced their plans today to test several potential small-molecule compounds to slow or stop the progression of Amyotrophic Lateral Sclerosis (ALS, Lou Gehrig's disease).

17 Mar 2010

Somanetics first-quarter 2010 net revenues up 18%

Somanetics Corporation reported net revenues of $13.1 million for the first quarter ended February 28, 2010, an 18 percent increase from $11.2 million in the same period of 2009.

17 Mar 2010

Meridian Bioscience revises fiscal 2010 guidance, expects net sales between $145M and $153M

Meridian Bioscience, Inc., Cincinnati, Ohio today announced that it is revising downward its previous sales and earnings guidance for the fiscal year ending September 30, 2010. This action is being taken as a result of weaker than expected operating results for the second quarter ending March 31, 2010, based on preliminary results to date. Separately, Meridian announced that it will file a 510(k) for FDA marketing clearance next week in connection with its illumigene™ C. difficile product.

17 Mar 2010

China Sky One Medical's 2009 fourth-quarter total revenues up 15.0%

China Sky One Medical, Inc., a leading fully integrated pharmaceutical company producing over-the-counter drugs in the People's Republic of China ("PRC"), today announced financial results for the fourth quarter and fiscal year ended December 31, 2009. The Company also announced its earnings guidance for full year 2010.

17 Mar 2010

Protalix BioTherapeutics commences clinical trial of human acetylcholinesterase for biodefense indications

Protalix BioTherapeutics, Inc. announced today that it has initiated a phase I clinical trial of PRX-105, the Company's plant cell expressed pegylated recombinant human acetylcholinesterase product candidate in development for biodefense indications. The trial is designed to study the safety of PRX-105 by administering a bolus intravenous injection of PRX-105 in healthy volunteers.

17 Mar 2010

Technology News and Research

FCC makes recommendations for using high-speed broadband networks to increase use of telemedicine

McGill researchers pioneer major breakthrough in DNA nanotechnology

Virtuoso Digital Pathology Software: BioImagene adds Companion Algorithms for colon cancer

U.N. Secretary-General launches report aimed at meeting MDGs by 2015

Bone Biologics receives Notice of Allowance of patent claims that protects formation of cartilage by UCB-1

NIST and HHS to develop software tools to support health IT testing infrastructure

FDA approves Envoy Medical's prosthetic hearing restoration device

RainDance Technologies partners with Ambry Genetics to provide sequence enrichment solution for clinical and research studies

Enzo Biochem announces supply and distribution agreement between Enzo Life Sciences and Cancer Genetics

Biomoda enters into agreements with syndicate of institutional investors for up to $2.0M

Industry game changers to watch in healthcare IT

Zogenix announces the initiation of pivotal Phase 3 clinical trial with ZX002

Use of simulation technology in Florida's nursing education programs expanding

ImmunoCellular Therapeutics receives Notice of Allowance covering antibodies targeting pancreatic cancer

CDISC approves Nextrials as one of 15 registered solutions providers

ALS TDI, Aestus Therapeutics to test potential small-molecule compounds to stop progression of ALS

Somanetics first-quarter 2010 net revenues up 18%

Meridian Bioscience revises fiscal 2010 guidance, expects net sales between $145M and $153M

China Sky One Medical's 2009 fourth-quarter total revenues up 15.0%

Protalix BioTherapeutics commences clinical trial of human acetylcholinesterase for biodefense indications

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News